Cite

HARVARD Citation

    Jamy, O. et al. (2022). Hypomethylating agent/venetoclax versus intensive chemotherapy in adults with relapsed or refractory acute myeloid leukaemia. British journal of haematology. pp. e35-e37. [Online]. 
  
Back to record